Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

November 30, 1996

Conditions
Cervical Cancer
Interventions
BIOLOGICAL

human papillomavirus 16 E7 peptide

BIOLOGICAL

synthetic human papillomavirus 16 E6 peptide

PROCEDURE

adjuvant therapy

PROCEDURE

surgical procedure

RADIATION

radiation therapy

Trial Locations (10)

6500

Nijmegen Cancer Center at Radboud University Medical Center, Nijmegen

75248

Institut Curie - Section Medicale, Paris

A-6020

Innsbruck Universitaetsklinik, Innsbruck

D-79106

Universitaetsklinikum Freiburg, Freiburg im Breisgau

D-80337

I. Frauenklinik und Hebammenschule der Ludwig-Maximillians Universitaet Muenchen, Munich

N-0310

Norwegian Radium Hospital, Oslo

S-581 85

University Hospital of Linkoping, Linköping

M13 0JH

St. Mary's Hospital, Manchester

DD1 9SY

Ninewells Hospital and Medical School, Dundee

CF14 2TL

Velindre Cancer Center at Velinde Hospital, Cardiff

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00002916 - Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer | Biotech Hunter | Biotech Hunter